Oral Oncology
Volume 48, Issue 2 , Pages 110-116 , February 2012

Vesicular stomatitis virus matrix protein (VSVMP) inhibits the cell growth and tumor angiogenesis in oral squamous cell carcinoma

Received 19 May 2011 ,Revised 12 August 2011 ,Accepted 14 September 2011.

References 

  1. Warnakulasuriya S. Global epidemiology of oral and oropharyngeal cancer. Oral Oncol. 2009;45(4–5):309–316
  2. Liu Xiqiang, Kolokythas Antonia, Wang Jianguang, Huang Hongzhang, Zhou Xiaofeng. Gene expression signatures of lymph node metastasis in oral cancer: molecular characteristics and clinical significances. Curr Cancer Ther Rev. 2010;6(4):294–307
  3. Fedele Stefano. Diagnostic aids in the screening of oral cancer. Head Neck Oncol. 2009;1:5
  4. Stief AE, McCart JA. Oncolytic virotherapy for multiple myeloma. Expert Opin Biol Ther. 2008;8(4):463–473
  5. Moussavi M, Fazli L, Tearle H, Guo Y, Cox M, Bell J, et al. Oncolysis of prostate cancers induced by vesicular stomatitis virus in PTEN knockout mice. Cancer Res. 2010;70(4):1367–1376
  6. Wu Y, Lun X, Zhou H, Wang L, Sun B, Bell JC, et al. Oncolytic efficacy of recombinant vesicular stomatitis virus and myxoma virus in experimental models of rhabdoid tumors. Clin Cancer Res. 2008;14(4):1218–1227
  7. Megyeri K, Orosz L, Kemény L. Vesicular stomatitis virus infection triggers apoptosis associated with decreased DeltaNp63alpha and increased Bax levels in the immortalized HaCaT keratinocyte cell line. Biomed Pharmacother. 2007;61(5):254–260
  8. Diaz RM, Galivo F, Kottke T, Wongthida P, Qiao J, Thompson J, et al. Oncolytic immunovirotherapy for melanoma using vesicular stomatitis virus. Cancer Res. 2007;67(6):2840–2848
  9. Letchworth GJ, Rodriguez LL, Del CBJ. Vesicular stomatitis. Vet J. 1999;157(3):239–260
  10. Shi W, Tang Q, Chen X, Cheng P, Jiang P, Jing X, et al. Antitumor and antimetastatic activities of vesicular stomatitis virus matrix protein in a murine model of breast cancer. J Mol Med. 2009;87(5):493–506
  11. Liu J, Prolla G, Rostagno A, Chiarle R, Feiner H, Inghirami G. Initiation of translation from a downstream in-frame AUG codon on BRCA1 can generate the novel isoform protein DBRCA1 (17aa). Oncogene. 2000;19(23):2767–2773
  12. Du XB, Lang JY, Xu JR, Lu Y, Wen YJ, Zhao JM, et al. Vesicular stomatitis virus matrix protein gene enhances the antitumor effects of radiation via induction of apoptosis. Apoptosis. 2008;13(10):1205–1214
  13. Zhong Q, Wen YJ, Yang HS, Luo H, Fu AF, Yang F, et al. Efficient inhibition of cisplatin-resistant human ovarian cancer growth and prolonged survival by gene transferred vesicular stomatitis virus matrix protein in nude mice. Ann Oncol. 2008;19(9):1584–1591
  14. Weidner N. Intratumoral microvessel density as a prognostic factor in cancer. Am J Pathol. 1995;147(1):33–41
  15. Shen Jun, Huang Canhua, Jiang Lu, Gao Feng, Wang Zhi, Zhang Yuanyuan, et al. Enhancement of cisplatin induced apoptosis by suberoylanilide hydroxamic acid in human oral squamous cell carcinoma cell lines. Biochem. Pharmacol. 2007;73(12):1901–1909
  16. Thomas SM, Grandis JR. The current state of head and neck cancer gene therapy. Hum Gene Ther. 2009;20(12):1565–1575
  17. Li Y, Li LJ, Zhang ST, Wang LJ, Zhang Z, Gao N, et al. In vitro and clinical studies of gene therapy with recombinant human adenovirus-p53 injection for oral leukoplakia. Clin Cancer Res. 2009;15(21):6724–6731
  18. Lin X, Chen X, Wei Y, Zhao J, Fan L, Wen Y, et al. Efficient inhibition of intraperitoneal human ovarian cancer growth and prolonged survival by gene transfer of vesicular stomatitis virus matrix protein in nude mice. Gynecol Oncol. 2007;104(3):540–546
  19. Black BL, Lyles DS. Vesicular stomatitis virus matrix protein inhibits host cell-directed transcription of target genes in vivo. J Virol. 1992;66(7):4058–4064
  20. Her LS, Lund E, Dahlberg JE. Inhibition of Ran guanosine triphosphatase dependent nuclear transport by the matrix protein of vesicular stomatitis virus. Science. 1997;276(5320):1845–1848
  21. Blondel D, Harmison GG, Schubert M. Role of matrix protein in cytopathogenesis of vesicular stomatitis virus. J Virol. 1990;64(4):1716–1725
  22. Zhao JM, Wen YJ, Li Q, Wang YS, Wu HB, Xu JR. A promising cancer gene therapy agent based on the matrix protein of vesicular stomatitis virus. FASEB J. 2008;22(12):4272–4280
  23. Shchors K, Evan G. Tumor angiogenesis: cause or consequence of cancer. Cancer Res. 2007;67(15):7059–7061
  24. Goodsell DS. The molecular perspective: VEGF and angiogenesis. Stem Cells. 2003;21(1):118–119

PII: S1368-8375(11)00822-0

doi: 10.1016/j.oraloncology.2011.09.007

Oral Oncology
Volume 48, Issue 2 , Pages 110-116 , February 2012

Article Tools

* Image Usage & Resolution